Filing Details
- Accession Number:
- 0001062993-23-002794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-10 21:49:26
- Reporting Period:
- 2023-02-09
- Accepted Time:
- 2023-02-10 21:49:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1270921 | J Andrew Grethlein | C/O Geron Corporation 919 E. Hillsdale Blvd, Suite 250 Foster City CA 94404 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-09 | 150,000 | $1.51 | 384,719 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-09 | 150,000 | $3.03 | 234,719 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-09 | 234,719 | $3.03 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-02-09 | 150,000 | $0.00 | 150,000 | $1.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-12 | No | 4 | M | Direct |
Footnotes
- The options were fully vested.
- This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023.
- Shares sold to meet tax obligations and pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023.
Billionaire Hedge Funds
